 | • レポートコード：MRC2-11QY04403 • 出版社/出版日：QYResearch / 2020年11月20日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、97ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：ヘルスケア |
| Single User | ￥577,200 (USD3,900) | ▷ お問い合わせ |
| Multi User | ￥865,800 (USD5,850) | ▷ お問い合わせ |
| Enterprise License | ￥1,154,400 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料は結節性痒疹治療のグローバル市場について調査・分析したレポートです。種類別（カプサイシンクリーム、抗ヒスタミン薬、その他）市場規模、用途別（病院薬局、小売薬局、オンライン薬局）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、台湾、中南米、メキシコ、ブラジル、アルゼンチン、中東・アフリカ、トルコ、サウジアラビア、UAE等）市場規模データ、主な企業情報と企業別市場シェア等が収録されています。 ・調査範囲 ・エグゼクティブサマリー ・企業別結節性痒疹治療の競争状況、市場シェア ・世界の結節性痒疹治療市場：種類別市場規模 2015年-2020年（カプサイシンクリーム、抗ヒスタミン薬、その他） ・世界の結節性痒疹治療市場：種類別市場規模予測 2021年-2026年（カプサイシンクリーム、抗ヒスタミン薬、その他） ・世界の結節性痒疹治療市場：用途別市場規模 2015年-2020年（病院薬局、小売薬局、オンライン薬局） ・世界の結節性痒疹治療市場：用途別市場規模予測 2021年-2026年（病院薬局、小売薬局、オンライン薬局） ・北米の結節性痒疹治療市場分析：米国、カナダ ・ヨーロッパの結節性痒疹治療市場分析：ドイツ、フランス、イギリス、イタリア、ロシア等 ・アジアの結節性痒疹治療市場分析：日本、中国、韓国、インド、オーストラリア、台湾等 ・中南米の結節性痒疹治療市場分析：メキシコ、ブラジル、アルゼンチン等 ・中東・アフリカの結節性痒疹治療市場分析：トルコ、サウジアラビア、UAE等 ・企業情報（企業概要、製品概要、販売量、企業動向） - 掲載企業（変更可能性あり）：Johnson & Johnson、GlaxoSmithKline、Pfizer、Teva Pharmaceutical、Bayer ・地域別市場規模予測（2021年-2026年）：北米市場、ヨーロッパ市場、アジア市場、中南米市場、中東・アフリカ市場 ・市場機会、課題、リスク、環境分析 ・バリューチェーン、販売チャネル分析 ・調査の結論 |
Prurigo nodularis (PN), also known as nodular prurigo, is a skin disease characterised by pruritic (itchy) nodules which usually appear on the arms or legs.
Among products, antihistamines are foreseen to exhibit a higher CAGR in the global prurigo nodularis treatment market.
Market Analysis and Insights: Global Prurigo Nodularis Treatment Market
The global Prurigo Nodularis Treatment market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026.
Global Prurigo Nodularis Treatment Scope and Market Size
Prurigo Nodularis Treatment market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Prurigo Nodularis Treatment market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.
The key players covered in this study
Johnson & Johnson
GlaxoSmithKline
Pfizer
Teva Pharmaceutical
Bayer
…
Market segment by Type, the product can be split into
Capsaicin Cream
Antihistamines
Others
Market segment by Application, split into
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
Market segment by Regions/Countries, this report covers
North America
Europe
China
Japan
Southeast Asia
India
1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Prurigo Nodularis Treatment Revenue
1.4 Market by Type
1.4.1 Global Prurigo Nodularis Treatment Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 Capsaicin Cream
1.4.3 Antihistamines
1.4.4 Others
1.5 Market by Application
1.5.1 Global Prurigo Nodularis Treatment Market Share by Application: 2020 VS 2026
1.5.2 Hospital Pharmacies
1.5.3 Retail Pharmacies
1.5.4 Online Pharmacies
1.6 Study Objectives
1.7 Years Considered
2 Global Growth Trends
2.1 Global Prurigo Nodularis Treatment Market Perspective (2015-2026)
2.2 Global Prurigo Nodularis Treatment Growth Trends by Regions
2.2.1 Prurigo Nodularis Treatment Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 Prurigo Nodularis Treatment Historic Market Share by Regions (2015-2020)
2.2.3 Prurigo Nodularis Treatment Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter’s Five Forces Analysis
2.3.5 Prurigo Nodularis Treatment Market Growth Strategy
2.3.6 Primary Interviews with Key Prurigo Nodularis Treatment Players (Opinion Leaders)
3 Competition Landscape by Key Players
3.1 Global Top Prurigo Nodularis Treatment Players by Market Size
3.1.1 Global Top Prurigo Nodularis Treatment Players by Revenue (2015-2020)
3.1.2 Global Prurigo Nodularis Treatment Revenue Market Share by Players (2015-2020)
3.1.3 Global Prurigo Nodularis Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Prurigo Nodularis Treatment Market Concentration Ratio
3.2.1 Global Prurigo Nodularis Treatment Market Concentration Ratio (CR5 and HHI)
3.2.2 Global Top 10 and Top 5 Companies by Prurigo Nodularis Treatment Revenue in 2019
3.3 Prurigo Nodularis Treatment Key Players Head office and Area Served
3.4 Key Players Prurigo Nodularis Treatment Product Solution and Service
3.5 Date of Enter into Prurigo Nodularis Treatment Market
3.6 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
4.1 Global Prurigo Nodularis Treatment Historic Market Size by Type (2015-2020)
4.2 Global Prurigo Nodularis Treatment Forecasted Market Size by Type (2021-2026)
5 Market Size by Application (2015-2026)
5.1 Global Prurigo Nodularis Treatment Market Size by Application (2015-2020)
5.2 Global Prurigo Nodularis Treatment Forecasted Market Size by Application (2021-2026)
6 North America
6.1 North America Prurigo Nodularis Treatment Market Size (2015-2020)
6.2 Prurigo Nodularis Treatment Key Players in North America (2019-2020)
6.3 North America Prurigo Nodularis Treatment Market Size by Type (2015-2020)
6.4 North America Prurigo Nodularis Treatment Market Size by Application (2015-2020)
7 Europe
7.1 Europe Prurigo Nodularis Treatment Market Size (2015-2020)
7.2 Prurigo Nodularis Treatment Key Players in Europe (2019-2020)
7.3 Europe Prurigo Nodularis Treatment Market Size by Type (2015-2020)
7.4 Europe Prurigo Nodularis Treatment Market Size by Application (2015-2020)
8 China
8.1 China Prurigo Nodularis Treatment Market Size (2015-2020)
8.2 Prurigo Nodularis Treatment Key Players in China (2019-2020)
8.3 China Prurigo Nodularis Treatment Market Size by Type (2015-2020)
8.4 China Prurigo Nodularis Treatment Market Size by Application (2015-2020)
9 Japan
9.1 Japan Prurigo Nodularis Treatment Market Size (2015-2020)
9.2 Prurigo Nodularis Treatment Key Players in Japan (2019-2020)
9.3 Japan Prurigo Nodularis Treatment Market Size by Type (2015-2020)
9.4 Japan Prurigo Nodularis Treatment Market Size by Application (2015-2020)
10 Southeast Asia
10.1 Southeast Asia Prurigo Nodularis Treatment Market Size (2015-2020)
10.2 Prurigo Nodularis Treatment Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Prurigo Nodularis Treatment Market Size by Type (2015-2020)
10.4 Southeast Asia Prurigo Nodularis Treatment Market Size by Application (2015-2020)
11 India
11.1 India Prurigo Nodularis Treatment Market Size (2015-2020)
11.2 Prurigo Nodularis Treatment Key Players in India (2019-2020)
11.3 India Prurigo Nodularis Treatment Market Size by Type (2015-2020)
11.4 India Prurigo Nodularis Treatment Market Size by Application (2015-2020)
12 Central & South America
12.1 Central & South America Prurigo Nodularis Treatment Market Size (2015-2020)
12.2 Prurigo Nodularis Treatment Key Players in Central & South America (2019-2020)
12.3 Central & South America Prurigo Nodularis Treatment Market Size by Type (2015-2020)
12.4 Central & South America Prurigo Nodularis Treatment Market Size by Application (2015-2020)
13 Key Players Profiles
13.1 Johnson & Johnson
13.1.1 Johnson & Johnson Company Details
13.1.2 Johnson & Johnson Business Overview
13.1.3 Johnson & Johnson Prurigo Nodularis Treatment Introduction
13.1.4 Johnson & Johnson Revenue in Prurigo Nodularis Treatment Business (2015-2020))
13.1.5 Johnson & Johnson Recent Development
13.2 GlaxoSmithKline
13.2.1 GlaxoSmithKline Company Details
13.2.2 GlaxoSmithKline Business Overview
13.2.3 GlaxoSmithKline Prurigo Nodularis Treatment Introduction
13.2.4 GlaxoSmithKline Revenue in Prurigo Nodularis Treatment Business (2015-2020)
13.2.5 GlaxoSmithKline Recent Development
13.3 Pfizer
13.3.1 Pfizer Company Details
13.3.2 Pfizer Business Overview
13.3.3 Pfizer Prurigo Nodularis Treatment Introduction
13.3.4 Pfizer Revenue in Prurigo Nodularis Treatment Business (2015-2020)
13.3.5 Pfizer Recent Development
13.4 Teva Pharmaceutical
13.4.1 Teva Pharmaceutical Company Details
13.4.2 Teva Pharmaceutical Business Overview
13.4.3 Teva Pharmaceutical Prurigo Nodularis Treatment Introduction
13.4.4 Teva Pharmaceutical Revenue in Prurigo Nodularis Treatment Business (2015-2020)
13.4.5 Teva Pharmaceutical Recent Development
13.5 Bayer
13.5.1 Bayer Company Details
13.5.2 Bayer Business Overview
13.5.3 Bayer Prurigo Nodularis Treatment Introduction
13.5.4 Bayer Revenue in Prurigo Nodularis Treatment Business (2015-2020)
13.5.5 Bayer Recent Development
14 Analyst’s Viewpoints/Conclusions
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details
Table 1. Prurigo Nodularis Treatment Key Market Segments
Table 2. Key Players Covered: Ranking by Prurigo Nodularis Treatment Revenue
Table 3. Ranking of Global Top Prurigo Nodularis Treatment Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Prurigo Nodularis Treatment Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of Capsaicin Cream
Table 6. Key Players of Antihistamines
Table 7. Key Players of Others
Table 8. Global Prurigo Nodularis Treatment Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 9. Global Prurigo Nodularis Treatment Market Size by Regions (US$ Million): 2020 VS 2026
Table 10. Global Prurigo Nodularis Treatment Market Size by Regions (2015-2020) (US$ Million)
Table 11. Global Prurigo Nodularis Treatment Market Share by Regions (2015-2020)
Table 12. Global Prurigo Nodularis Treatment Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 13. Global Prurigo Nodularis Treatment Market Share by Regions (2021-2026)
Table 14. Market Top Trends
Table 15. Key Drivers: Impact Analysis
Table 16. Key Challenges
Table 17. Prurigo Nodularis Treatment Market Growth Strategy
Table 18. Main Points Interviewed from Key Prurigo Nodularis Treatment Players
Table 19. Global Prurigo Nodularis Treatment Revenue by Players (2015-2020) (Million US$)
Table 20. Global Prurigo Nodularis Treatment Market Share by Players (2015-2020)
Table 21. Global Top Prurigo Nodularis Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Prurigo Nodularis Treatment as of 2019)
Table 22. Global Prurigo Nodularis Treatment by Players Market Concentration Ratio (CR5 and HHI)
Table 23. Key Players Headquarters and Area Served
Table 24. Key Players Prurigo Nodularis Treatment Product Solution and Service
Table 25. Date of Enter into Prurigo Nodularis Treatment Market
Table 26. Mergers & Acquisitions, Expansion Plans
Table 27. Global Prurigo Nodularis Treatment Market Size by Type (2015-2020) (Million US$)
Table 28. Global Prurigo Nodularis Treatment Market Size Share by Type (2015-2020)
Table 29. Global Prurigo Nodularis Treatment Revenue Market Share by Type (2021-2026)
Table 30. Global Prurigo Nodularis Treatment Market Size Share by Application (2015-2020)
Table 31. Global Prurigo Nodularis Treatment Market Size by Application (2015-2020) (Million US$)
Table 32. Global Prurigo Nodularis Treatment Market Size Share by Application (2021-2026)
Table 33. North America Key Players Prurigo Nodularis Treatment Revenue (2019-2020) (Million US$)
Table 34. North America Key Players Prurigo Nodularis Treatment Market Share (2019-2020)
Table 35. North America Prurigo Nodularis Treatment Market Size by Type (2015-2020) (Million US$)
Table 36. North America Prurigo Nodularis Treatment Market Share by Type (2015-2020)
Table 37. North America Prurigo Nodularis Treatment Market Size by Application (2015-2020) (Million US$)
Table 38. North America Prurigo Nodularis Treatment Market Share by Application (2015-2020)
Table 39. Europe Key Players Prurigo Nodularis Treatment Revenue (2019-2020) (Million US$)
Table 40. Europe Key Players Prurigo Nodularis Treatment Market Share (2019-2020)
Table 41. Europe Prurigo Nodularis Treatment Market Size by Type (2015-2020) (Million US$)
Table 42. Europe Prurigo Nodularis Treatment Market Share by Type (2015-2020)
Table 43. Europe Prurigo Nodularis Treatment Market Size by Application (2015-2020) (Million US$)
Table 44. Europe Prurigo Nodularis Treatment Market Share by Application (2015-2020)
Table 45. China Key Players Prurigo Nodularis Treatment Revenue (2019-2020) (Million US$)
Table 46. China Key Players Prurigo Nodularis Treatment Market Share (2019-2020)
Table 47. China Prurigo Nodularis Treatment Market Size by Type (2015-2020) (Million US$)
Table 48. China Prurigo Nodularis Treatment Market Share by Type (2015-2020)
Table 49. China Prurigo Nodularis Treatment Market Size by Application (2015-2020) (Million US$)
Table 50. China Prurigo Nodularis Treatment Market Share by Application (2015-2020)
Table 51. Japan Key Players Prurigo Nodularis Treatment Revenue (2019-2020) (Million US$)
Table 52. Japan Key Players Prurigo Nodularis Treatment Market Share (2019-2020)
Table 53. Japan Prurigo Nodularis Treatment Market Size by Type (2015-2020) (Million US$)
Table 54. Japan Prurigo Nodularis Treatment Market Share by Type (2015-2020)
Table 55. Japan Prurigo Nodularis Treatment Market Size by Application (2015-2020) (Million US$)
Table 56. Japan Prurigo Nodularis Treatment Market Share by Application (2015-2020)
Table 57. Southeast Asia Key Players Prurigo Nodularis Treatment Revenue (2019-2020) (Million US$)
Table 58. Southeast Asia Key Players Prurigo Nodularis Treatment Market Share (2019-2020)
Table 59. Southeast Asia Prurigo Nodularis Treatment Market Size by Type (2015-2020) (Million US$)
Table 60. Southeast Asia Prurigo Nodularis Treatment Market Share by Type (2015-2020)
Table 61. Southeast Asia Prurigo Nodularis Treatment Market Size by Application (2015-2020) (Million US$)
Table 62. Southeast Asia Prurigo Nodularis Treatment Market Share by Application (2015-2020)
Table 63. India Key Players Prurigo Nodularis Treatment Revenue (2019-2020) (Million US$)
Table 64. India Key Players Prurigo Nodularis Treatment Market Share (2019-2020)
Table 65. India Prurigo Nodularis Treatment Market Size by Type (2015-2020) (Million US$)
Table 66. India Prurigo Nodularis Treatment Market Share by Type (2015-2020)
Table 67. India Prurigo Nodularis Treatment Market Size by Application (2015-2020) (Million US$)
Table 68. India Prurigo Nodularis Treatment Market Share by Application (2015-2020)
Table 69. Central & South America Key Players Prurigo Nodularis Treatment Revenue (2019-2020) (Million US$)
Table 70. Central & South America Key Players Prurigo Nodularis Treatment Market Share (2019-2020)
Table 71. Central & South America Prurigo Nodularis Treatment Market Size by Type (2015-2020) (Million US$)
Table 72. Central & South America Prurigo Nodularis Treatment Market Share by Type (2015-2020)
Table 73. Central & South America Prurigo Nodularis Treatment Market Size by Application (2015-2020) (Million US$)
Table 74. Central & South America Prurigo Nodularis Treatment Market Share by Application (2015-2020)
Table 75. Johnson & Johnson Company Details
Table 76. Johnson & Johnson Business Overview
Table 77. Johnson & Johnson Product
Table 78. Johnson & Johnson Revenue in Prurigo Nodularis Treatment Business (2015-2020) (Million US$)
Table 79. Johnson & Johnson Recent Development
Table 80. GlaxoSmithKline Company Details
Table 81. GlaxoSmithKline Business Overview
Table 82. GlaxoSmithKline Product
Table 83. GlaxoSmithKline Revenue in Prurigo Nodularis Treatment Business (2015-2020) (Million US$)
Table 84. GlaxoSmithKline Recent Development
Table 85. Pfizer Company Details
Table 86. Pfizer Business Overview
Table 87. Pfizer Product
Table 88. Pfizer Revenue in Prurigo Nodularis Treatment Business (2015-2020) (Million US$)
Table 89. Pfizer Recent Development
Table 90. Teva Pharmaceutical Company Details
Table 91. Teva Pharmaceutical Business Overview
Table 92. Teva Pharmaceutical Product
Table 93. Teva Pharmaceutical Revenue in Prurigo Nodularis Treatment Business (2015-2020) (Million US$)
Table 94. Teva Pharmaceutical Recent Development
Table 95. Bayer Company Details
Table 96. Bayer Business Overview
Table 97. Bayer Product
Table 98. Bayer Revenue in Prurigo Nodularis Treatment Business (2015-2020) (Million US$)
Table 99. Bayer Recent Development
Table 100. Research Programs/Design for This Report
Table 101. Key Data Information from Secondary Sources
Table 102. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Prurigo Nodularis Treatment Market Share by Type: 2020 VS 2026
Figure 2. Capsaicin Cream Features
Figure 3. Antihistamines Features
Figure 4. Others Features
Figure 5. Global Prurigo Nodularis Treatment Market Share by Application: 2020 VS 2026
Figure 6. Hospital Pharmacies Case Studies
Figure 7. Retail Pharmacies Case Studies
Figure 8. Online Pharmacies Case Studies
Figure 9. Prurigo Nodularis Treatment Report Years Considered
Figure 10. Global Prurigo Nodularis Treatment Market Size YoY Growth 2015-2026 (US$ Million)
Figure 11. Global Prurigo Nodularis Treatment Market Share by Regions: 2020 VS 2026
Figure 12. Global Prurigo Nodularis Treatment Market Share by Regions (2021-2026)
Figure 13. Porter's Five Forces Analysis
Figure 14. Global Prurigo Nodularis Treatment Market Share by Players in 2019
Figure 15. Global Top Prurigo Nodularis Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Prurigo Nodularis Treatment as of 2019
Figure 16. The Top 10 and 5 Players Market Share by Prurigo Nodularis Treatment Revenue in 2019
Figure 17. North America Prurigo Nodularis Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 18. Europe Prurigo Nodularis Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 19. China Prurigo Nodularis Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 20. Japan Prurigo Nodularis Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 21. Southeast Asia Prurigo Nodularis Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 22. India Prurigo Nodularis Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 23. Central & South America Prurigo Nodularis Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 24. Bottom-up and Top-down Approaches for This Report
Figure 25. Data Triangulation
Figure 26. Key Executives Interviewed
クッシング病治療の世界市場（～2026年） Cushing disease is caused by tumour in the pituitary gland which leads to excessive secretion of a hormone called adrenocorticotrophic (ACTH), which in turn leads to increasing levels of cortisol in the body. Cortisol is a steroid hormone released by the adrenal glands and helps the body to deal wit…- 変形性関節症治療の世界市場（～2026年） Osteoarthritis (OA) is a type of joint disease that results from breakdown of joint cartilage and underlying bone. The most common symptoms are joint pain and stiffness. Initially, symptoms may occur only following exercise, but over time may become constant. Other symptoms may include joint swellin…
- 萎縮性胃炎治療の世界市場（～2026年） Atopic gastritis is chronic inflammation of gastric mucosa, and it is a histopathological condition associated with gastric glandular cell and replacement by fibrous tissue, intestinal type epithelium, and pyloric type glands. It mainly associated H. Pylori bacterial infection, and autoimmunity dire…
- ブドウ膜炎治療の世界市場（～2026年） Uveitis is considered to be the leading cause for blindness in the U.S. with a gradual rise in prevalence. North America and APAC regions expected to be major contributors in the expansion of the global uveitis treatment market. Market Analysis and Insights: Global Uveitis Treatment Market The globa…
- 脂漏性皮膚炎治療の世界市場（～2026年） Seborrhoeic dermatitis is a long-term skin disorder. Seborrhoeic dermatitis symptoms include red, scaly, greasy, itchy and inflamed skin. Market Analysis and Insights: Global Seborrheic Dermatitis Treatment Market The global Seborrheic Dermatitis Treatment market size is projected to reach US$ XX mi…